13F Holdings
中文EN

MTEX MANNATECH INC

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1056358 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-6.6%
TTM net income YoY74.3%
TTM EPS YoY64.0%
Revenue 3-yr CAGR-8.3%
Net income 3-yr CAGR—

Margins

Gross margin75.7%
Operating margin0.9%
Net margin-0.4%
FCF margin-0.6%
EBITDA margin1.9%

Returns

ROE-7.0%
ROA-1.4%
ROIC (approx.)17.8%
Asset turnover3.33x

Leverage & solvency

Liabilities / assets81.3%
Debt / equity0.53x
Current ratio1.18x
Interest coverage2.00x

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$108.04M$117.87M$131.96M$137.21M$159.76M
Cost of revenue$27.08M$26.41M$29.09M$33.06M$34.15M
Gross profit$80.96M$91.46M$102.86M$104.15M$125.61M
R&D expense$800,000$700,000$800,000$1.00M$1.20M
SG&A expense$39.66M$41.72M$50.24M$47.44M$29.43M
Operating income-$426,000$1.43M-$964,000-$405,000$9.05M
Interest expense$406,000$279,000———
Pretax income-$2.89M$3.74M-$1.13M-$479,000$8.89M
Income tax$12.32M$1.25M$1.11M$4.01M-$950,000
Net income-$15.21M$2.49M-$2.24M-$4.49M$9.84M
EBITDA$666,000$2.96M$664,000$1.22M$10.77M
EPS (basic)-8.001.32-1.20-2.354.95
EPS (diluted)-8.001.32-1.20-2.354.71
Dividends declared per share——0.20——
Weighted avg. shares (diluted)1.90M1.89M1.87M1.91M2.09M
Banking
Net interest income—-$279,000$4,000$88,000$66,000
Balance sheet
Cash & equivalents$6.18M$11.40M$9.39M$15.20M$24.18M
Receivables$1,000$19,000$91,000$200,000$100,000
Inventory$10.12M$10.40M$14.54M$14.73M$12.02M
Current assets$20.58M$26.12M$27.66M$34.95M$42.84M
PP&E, net$3.14M$2.71M$4.15M$3.76M$4.24M
Intangibles$237,000$237,000———
Total assets$29.99M$36.06M$41.21M$49.13M$59.62M
Current liabilities$18.73M$20.90M$25.78M$29.84M$30.10M
Long-term debt$2.75M————
Total debt$2.75M————
Total liabilities$35.22M$27.44M$30.72M$34.95M$35.21M
Shareholders' equity-$5.22M$8.61M$10.48M$14.18M$24.41M
Net debt-$3.44M————
Shares outstanding1.90M1.88M1.86M1.86M1.94M
Cash flow statement
Operating cash flow-$2.96M$2.26M-$2.37M-$2.60M$10.77M
Capital expenditure$1.35M$297,000$748,000$1.06M$650,000
Free cash flow-$4.32M$1.96M-$3.12M-$3.66M$10.12M
Investing cash flow-$1.35M-$285,000-$747,000-$1.06M-$650,000
Financing cash flow-$561,000$1.96M-$1.90M-$4.33M-$9.29M
Depreciation & amortization$1.09M$1.53M$1.63M$1.63M$1.72M
Stock-based compensation$379,000$291,000$278,000$337,000$260,000
Dividends paid—$0$748,000$1.53M$4.35M
Share buybacks—$0$176,000$1.98M$5.05M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.